학술논문
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition
Document Type
Article
Author
Source
In: Cell Communication and Signaling . (Cell Communication and Signaling, December 2023, 21(1))
Subject
Language
English
ISSN
1478811X